Latest News
Canaccord Genuity looks forward to vaccinations and M&A, lays out top picks for 2021
Analysts at Canaccord Genuity laid out their 'top picks' for the UK market over the next 12 months after a bruising 2020.
London midday: Stocks in the red as govt considers tighter restrictions
London stocks were still in the red by midday on Monday amid reports that Covid-19 restrictions in England were set to get even tougher.
Heathrow passengers plunge as new virus strain hits travel
The number of passengers travelling through Heathrow airport plunged 83% in December as the new strain of Covid-19 took its toll on air travel.
EasyJet secures five-year state-backed $1.87bn loan facility
Budget airline easyJet has strengthened its balance sheet by signing a new five-year $1. 87bn (£1. 4bn) term loan facility to help it deal with the continuing impact of the coronavirus pandemic.
Assura ramps up third-quarter investment, makes 'strong progress'
Assura hailed strong progress in the third quarter on Monday, after it secured a spate of acquisitions and completed three developments.
InnovaDerma to shore up balance sheet, sacks chairman
InnovaDerma shares dropped after the beauty products company said it was considering options to strengthen its balance sheet and had sacked its executive chairman.
Unite offers rent discount to students learning from home
Student accommodation developer and operator Unite Group announced a rent discount on Monday, as a result of the current Covid-19 lockdown, as it also reported 'modest' rises in its quarterly valuations.
Asia report: Markets mostly lower as China PPI deflation continues
Most markets in Asia closed in negative territory on Monday, as investors digested the latest economic data out of China and monitored the global Covid-19 situation.
US pre-open: Stocks to fall after last week's gains
US stocks were set for a weaker open on Monday following record highs last week.
Sanofi to buy biopharmaceutical group Kymab for up to $1.45bn
Sanofi has agreed to buy British clinical-stage biopharmaceutical company Kymab for up to $1. 45bn.
Strong demand puts MJ Gleeson on track to hit full-year targets
MJ Gleeson said on Monday that it was on track to deliver full-year results "at least" in line with expectations, after strong demand throughout the first half.
Vodafone and Telefonica commercialise towers joint venture
Vodafone and Telefonica have announced the commercialisation of the joint venture that manages their UK passive tower infrastructure.
JD Sports sees FY profit 'significantly' ahead of market expectations
JD Sports Fashion said on Monday that it is confident headline pre-tax profit for the year to 30 January will be "significantly" ahead of current market expectations of around £295m as demand has remained robust throughout the second half, including the key months of November and December.
China consumer prices rise in December
Chinese consumer prices unexpectedly rose in December but core inflation weakened to a 10-year low.
Direct Line CFO Tim Harris to take leave of absence
Direct Line said on Monday that chief financial officer Tim Harris will be taking a leave of absence with immediate effect whilst a family member undergoes medical treatment.
London open: Stocks fall amid prospect of tighter restrictions
London stocks fell in early trade on Monday amid reports that Covid-19 restrictions in England were set to get even tougher.
Europe open: Shares start week lower as Covid cases rise
European shares opened the first session of the week lower, as fears over the growing number of coronavirus cases dampened sentiment.
FCA warns consumers on crypto investing as Bitcoin falls
The Financial Conduct Authority warned consumers they should be prepared to lose all their money when making investments linked to cryptoassets as the values of Bitcoin and other digital currencies fell sharply.
GIP lands Signature aviation in $4.36bn deal
Gatwick Airport co-owner Global Infrastructure Partners has swooped to buy Signature Aviation for $4. 63bn (£3. 43bn), beating a rival offer from private equity outfit Blackstone Group and Microsoft founder Bill Gates.
Smith & Nephew revenues to drop as more procedures postponed
Medical technology company Smith & Nephew said on Monday that it expects to report a 7% decline in fourth-quarter underlying revenue and a 12% drop in full-year revenues, as more medical procedures are postponed due to rising numbers of coronavirus infections.